At In the Pipeline, Derek Lowe discusses a recent paper in PLoS Medicine that estimates that drug companies spent $57.5 billion on marketing in 2004 -- nearly twice what was spent on R&D. The authors, Marc-André Gagnon and Joel Lexchin, say that those figures show that advertising is more important than R&D to the pharmaceutical industry. Lowe says the authors missed a major point -- advertising, in the long run, brings in more money than the cost of the campaign. "Drug research involves money, and plenty of it. Advertising brings in more money, which is why it exists," he writes.
We'll Take a Slice of that $57.5 Billion
Jan 09, 2008